Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02239640 · ClinicalTrials.gov registry record
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
A clinical trial, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- 984
- Enrollment target
NCT02239640 is a clinical trial that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 984 participants.
The verdict
NCT02239640 has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- 984 participants
- Enrollment target
Study Summary
The purpose of this registry is to assess clinical outcomes, and different factors that may affect these clinical outcomes such as systems of care, associated with the use of Covidien market-released neurothrombectomy devices intended to restore blood flow in patients experiencing acute ischemic stroke due to large intracranial vessel occlusion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 984 participants |
| Start Date | 2014-08-21 |
| Est. Completion | 2016-10-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02239640
The ClinicalTrials.gov registry entry for NCT02239640 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 984 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02239640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02239640 about?
NCT02239640 is a clinical study titled "Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry". The purpose of this registry is to assess clinical outcomes, and different factors that may affect these clinical outcomes such as systems of care, associated with the use of Covidien market-released neurothrombectomy devices intended to restore blood flow in patients experiencing acute ischemic str...
What is the current status of trial NCT02239640?
This trial is currently completed. The enrollment target is 984 participants. The study started on 2014-08-21. Estimated completion is 2016-10-07.
Who is sponsoring clinical trial NCT02239640?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.